"Transfusion Reaction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
| Descriptor ID |
D065227
|
| MeSH Number(s) |
C15.378.962 C20.920
|
| Concept/Terms |
Transfusion Reaction- Transfusion Reaction
- Transfusion Reactions
- Blood Transfusion-Associated Adverse Reactions
- Blood Transfusion Associated Adverse Reactions
Hemolytic Transfusion Reaction- Hemolytic Transfusion Reaction
- Hemolytic Transfusion Reactions
- Reaction, Hemolytic Transfusion
- Reactions, Hemolytic Transfusion
- Transfusion Reaction, Hemolytic
- Transfusion Reactions, Hemolytic
Transfusion-Transmitted Infection- Transfusion-Transmitted Infection
- Infection, Transfusion-Transmitted
- Transfusion Transmitted Infection
- Transfusion-Transmitted Infections
Transfusion-Associated Circulatory Overload- Transfusion-Associated Circulatory Overload
- Circulatory Overload, Transfusion-Associated
- Circulatory Overloads, Transfusion-Associated
- Transfusion Associated Circulatory Overload
- Transfusion-Associated Circulatory Overloads
Hypotensive Transfusion Reaction- Hypotensive Transfusion Reaction
- Reaction, Hypotensive Transfusion
- Transfusion Reaction, Hypotensive
- Transfusion Reactions, Hypotensive
|
Below are MeSH descriptors whose meaning is more general than "Transfusion Reaction".
Below are MeSH descriptors whose meaning is more specific than "Transfusion Reaction".
This graph shows the total number of publications written about "Transfusion Reaction" by people in this website by year, and whether "Transfusion Reaction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 2 | 2 | 4 |
| 2015 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 2 | 1 | 3 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transfusion Reaction" by people in Profiles.
-
Evaluation of a pediatric patient blood management program: A pre-/post-study. Transfusion. 2026 Mar; 66(3):507-514.
-
Transfusion-related iron overload in survivors of childhood cancer. Blood Cells Mol Dis. 2026 Mar; 117:102977.
-
Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial. Transfusion. 2026 Jan; 66(1):84-93.
-
Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome. Transfusion. 2025 May; 65(5):1001-1006.
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
-
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. Transfusion. 2023 09; 63(9):1639-1648.
-
Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress. J Infus Nurs. 2022 Sep-Oct 01; 45(5):264-269.
-
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 07; 18(7):435-453.
-
Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. Pediatr Crit Care Med. 2019 02; 20(2):e61-e69.
-
An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016 Mar; 214(3):340-4.